Skip to content

An Integrative Multi-Omic Characterization of Head and Neck Carcinogenesis, Progression and Recurrence

An Integrative Multi-Omic Characterization of Head and Neck Carcinogenesis, Progression and Recurrence

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT06420219
Enrollment
50
Registered
2024-05-17
Start date
2024-03-25
Completion date
2029-03-25
Last updated
2026-04-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Head and Neck Carcinoma

Brief summary

This study evaluates the cell and biomarkers associated with the aggressive behavior of cancer.

Detailed description

PRIMARY OBJECTIVE: I. High-resolution single-cell profiling of Cancer-associated fibroblasts (CAFs) in Human papillomavirus (HPV)+ Oropharyngeal Squamous Cell Carcinoma (OPSCC) and metastatic lymph nodes. OUTLINE: This is an observational study. Patients undergo photography, blood sample collection, tissue collection and have their medical records reviewed on study.

Interventions

OTHERNon-Interventional Study

Non-interventional study

Sponsors

University of Southern California
Lead SponsorOTHER
National Cancer Institute (NCI)
CollaboratorNIH
American Academy of Otolaryngology-Head and Neck Surgery Foundation
CollaboratorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Diagnosis/disease status: New diagnosis of head and neck cancer * Allowable type and amount of prior therapy: No prior treatment * Age ≥ 18 years. * Ability to understand and the willingness to sign a written informed consent.

Exclusion criteria

* Patients who have had treatment of head and neck cancer

Design outcomes

Primary

MeasureTime frame
Overall survivalUp to 5 years
Disease free survivalUp to 5 years

Countries

United States

Contacts

CONTACTSandy Tran, MS
sandy.tran@med.usc.edu323-865-0451
PRINCIPAL_INVESTIGATORAlbert Y Han, MD

University of Southern California

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Apr 29, 2026